A phase II trial of high-dose bromodeoxyuridine with accelerated fractionation radiotherapy followed by procarbazine, lomustine, and vincristine for glioblastoma multiforme. [electronic resource]
Producer: 19990920Description: 127-35 p. digitalISSN:- 0360-3016
- Adult
- Aged
- Antimetabolites, Antineoplastic -- administration & dosage
- Antineoplastic Combined Chemotherapy Protocols -- administration & dosage
- Brain Neoplasms -- drug therapy
- Bromodeoxyuridine -- administration & dosage
- Cognition -- drug effects
- Combined Modality Therapy
- Disease Progression
- Disease-Free Survival
- Female
- Glioblastoma -- drug therapy
- Humans
- Lomustine -- administration & dosage
- Male
- Middle Aged
- Procarbazine -- administration & dosage
- Radiation-Sensitizing Agents -- administration & dosage
- Reoperation
- Vincristine -- administration & dosage
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.